Cybersecurity Teams Can’t Keep up With Growing Levels of Cyberattacks, New Research Reveals
52% of cyber professionals feel that their budget is underfunded
Cybersecurity teams are under strain, as 61% of European cybersecurity professionals say that their organisation’s cybersecurity team is understaffed, and over half (52%) believe that their organisation’s cybersecurity budget is underfunded. That’s according to new research from ISACA, the leading global professional association helping individuals and organisations in their pursuit of digital trust.
Staff and funding struggles are having an impact on wellbeing as 68% feel that their role is more stressful now compared to five years ago, with 79% putting this down to the increasingly complex threat landscape.
Two in five (41%) of respondents say they are experiencing more cyberattacks when compared to a year ago, and 29% think they are experiencing the same amount.
But respondents don’t feel the number of attacks will be slowing down any time soon. Over half (58%) state it is likely their organisation will experience a cyberattack in the next year. This has increased by 6 percentage points (52%) compared to 2023 so there needs to be more investment in the right staff and skills to prepare and respond to these attacks to limit long term damage.
Chris Dimitriadis, Chief Global Strategy Officer at ISACA, said: “In an increasingly complex threat landscape, it is vital that, as an industry, we overcome these hurdles of underfunding and under-staffed teams. Without strong, skilled teams, the security resilience of whole ecosystems is at risk – leaving critical infrastructure vulnerable.”
Despite the need for skilled teams to protect businesses, 19% say that their organisation has unfilled and open entry-level positions available, and 48% have unfilled open positions which require experience, a university degree, or other credentials. These figures have dropped only a few percentage points (from 22% and 53%) since 2023, pointing to an ongoing struggle to fill open positions.
52% of respondents say that soft skills are lacking the most amongst today’s cybersecurity professionals. Of the soft skills in question, 54% feel that communication skills (e.g. speaking and listening skills) are most important, followed by problem-solving (53%) and critical thinking (48%).
Dimitriadis added: “The cybersecurity industry will massively benefit from a diverse range of people – each with different skills, experiences, and perspectives. This is the key to plugging the skills gap. Once talent enters the industry, businesses can then train and upskill new entrants on the job with cyber certifications and qualifications.”
Mike Mellor, Vice President, Security Engineering at Adobe, who sponsored the research, said: “With the increasing frequency and sophistication of cyberattacks, it’s essential for organisations to adopt secure authentication methods to strengthen their defences. Adobe believes that fostering a deep security culture among all employees through anti-phishing training, combined with stronger controls such as zero-trust networks protected by phishing-resistant authentication are essential in safeguarding any organisation.”
Notes to Editors
On May 3, 2024, an online survey was sent to approximately 39,000 ISACA members and non-members, globally, holding a CISM certification OR having “security” in their job title, asking their opinions on the state of cybersecurity within their organization. As this respondent pool is comprised entirely of ISACA members or ISACA certification holders, within limited geographies and industries, it should not be interpreted to represent the entire IT Security population. 1,868 respondents completed the entire survey, with a margin of error of +/- 2 points at the 95% confidence level. Note that response rates vary by question.
About ISACA
For more than 50 years, ISACA® (www.isaca.org) has equipped individuals and enterprises with the knowledge, credentials, education, training and community to progress their careers, transform their organizations, and build a more trusted and ethical digital world. ISACA is a global professional association and learning organization that leverages the expertise of its 180,000 members who work in digital trust fields such as information security, governance, assurance, risk, privacy and quality. It has a presence in 188 countries, including 225 chapters worldwide. Through the ISACA Foundation, ISACA supports IT education and career pathways for underresourced and underrepresented populations.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241001858650/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
ImmunAbs Announces FDA Phase 2 IND Approval of IM-101, a Novel Complement C5 Inhibitor, for Treatment of Myasthenia Gravis2.6.2025 13:00:00 CEST | Press release
ImmunAbs Inc., a clinical-stage biotech specializing in developing antibody therapeutics, today announced that the U.S. Food and Drug Administration has cleared its Investigational New Drug (IND) application to initiate a Phase 2 clinical trial evaluating the safety and efficacy of IM-101, a novel complement C5 inhibitor, for the treatment of Myasthenia Gravis. The forthcoming multicenter, randomized, double-blind, placebo-controlled study will enroll up to 90 patients to evaluate the effectiveness and safety of monthly IM-101 dosing in relieving complement-induced symptoms in MG. “This IND approval is pivotal for us as it brings us one step closer to delivering a transformative therapy for patients with autoimmune disorders”, said Dr. Dongjo Kim, the CEO of ImmunAbs, “we believe IM-101 has the potential to deliver deeper therapeutic responses and more durable remissions in patients who have failed to achieve sustained remission with current approved treatment.” About Myasthenia Gravis
Lenovo and Bellevue University Team Up to Offer Supply Chain and Logistics Education to Deliver “Smarter Technology for All”2.6.2025 13:00:00 CEST | Press release
Learners will have access to Lenovo’s globally recognized supply chain expertise through real-world case studies and subject matter experts. Lenovo, the global technology powerhouse, recognized in the top 10 in the Gartner Supply Chain Top 25, and Bellevue University, one of the nation’s top online universities, are teaming up to develop the next generation of supply chain professionals. “We believe that bringing real-world Global Supply Chain experience and learning directly into an education curriculum is precisely the optimal way to upskill the workforce of the future,” said Ben Massie, Vice President, Global Supply Chain, Lenovo. “Teaming up with Bellevue allows us to attract the right talent using the right technology and deliver on our mission to make ‘smarter technology for all’ a reality.” As a preferred higher education institution tapped to team up with Lenovo to offer supply chain short-term learning, Bellevue will leverage the breadth and depth of Lenovo’s supply chain expe
Lifezone Metals Files Initial Assessment for the Kabanga Nickel Project in Tanzania2.6.2025 12:30:00 CEST | Press release
Vertically Integrated Plan includes Hydrometallurgical Refinery at Kahama $2.37 Billion After-Tax NPV (8%) and 22.9% After-Tax IRR at $8.49 per Pound Nickel Price Initial Assessment Proposes a 22-Year Mine Plan at Average 2.39% Nickel Equivalent Grade Webcast with Technical Leadership Team at 10 AM ET on Tuesday, June 3, 2025 Lifezone Metals Limited’s (NYSE: LZM) Chief Executive Officer, Chris Showalter, and Chief Operating Officer, Gerick Mouton, announce today the results from the Initial Assessment for its flagship Kabanga Nickel Project in northwest Tanzania. The Initial Assessment evaluates a vertically integrated mining, processing and refining operation, commencing with a high-grade nickel sulfide underground mine and concentrator at the Kabanga site, followed five years later by a hydrometallurgical refinery at Kahama. The study covers the Main, MNB, Kima, North, and Tembo zones and is based on the December 2024 Mineral Resource Update (refer to Lifezone’s December 5, 2024 news
Corpay Cross-Border Named an Official Partner of Real Madrid C.F.2.6.2025 12:00:00 CEST | Press release
Providing access to currency risk management and cross-border payments solutions Corpay, Inc.*, (NYSE: CPAY) a global leader in corporate payments, is pleased to announce that Corpay’s Cross-Border business has entered into an agreement with Real Madrid C.F. to become an Official Partner. Through this partnership, Real Madrid will be able to gain access to and utilise Corpay Cross Border’s innovative solutions to help mitigate foreign exchange exposure from their day-to-day business needs. "The Corpay Cross-Border team is elated to be named an Official Partner of Real Madrid, one of the world’s most widely recognized and followed sports franchises," said Brad Loder, Chief Marketing Officer, Corpay Cross-Border Solutions. “With our strong focus on growing the Corpay brand, as well as our currency risk management business, we are excited to partner with one of the most successful football clubs in the world.” About Corpay Corpay, Inc. (NYSE: CPAY) is a global S&P500 corporate payments co
BeOne Medicines Unveils Promising Clinical Data for Two Novel Breast Cancer Therapies at ASCO 20252.6.2025 12:00:00 CEST | Press release
Preliminary results highlight anti-tumor activity and favorable safety profiles of both B7-H4-targeting ADC and CDK2 inhibitorData underscore strength of emerging breast cancer pipeline as part of BeOne’s global transformation with next wave of innovation BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, announced new clinical data from its emerging breast cancer pipeline at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago. Poster presentations feature preliminary results of the dose escalation studies of two investigational molecules: BG-C9074, a novel B7-H4-targeting antibody-drug conjugate (ADC) in patients with advanced solid tumors, including breast cancer, and BG-68501, a cyclin-dependent kinase-2 inhibitor (CDK2i), in HR+/HER2- breast cancer patients with prior CDK4/6i exposure. “Presenting the first clinical data for two novel breast cancer candidates at ASCO 2025 marks a pivotal moment for BeOne,” said Mark Lanas
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom